NxGen MDx Announces New Early Advantage Carrier Screening Panel
Retrieved on:
Wednesday, September 15, 2021
Program, Lists of diseases, Newborn screening, Fatty-acid metabolism disorder, Gestational age, PMID, Infant, Genetic testing, Health, Failure, Effect, Doctor of Philosophy, Patient, Pediatrics, LLC, Child, Mortality, Birth weight, MCADD, HHS, Collection, Philosophy, Pregnancy, NBS, Office of Inspector General, U.S. Department of Health and Human Services, Parent, Face, Time, Life, Lois Scharf, U.S. Department of Defense Strategy for Operating in Cyberspace, H, Birth control, Pharmaceutical industry
GRAND RAPIDS, Mich., Sept. 15, 2021 /PRNewswire/ -- NxGen MDx is taking an innovative approach to genetic carrier screening panel design by creating the Early Advantage Panel.
Key Points:
- GRAND RAPIDS, Mich., Sept. 15, 2021 /PRNewswire/ -- NxGen MDx is taking an innovative approach to genetic carrier screening panel design by creating the Early Advantage Panel.
- This panel is the first of its size to fully incorporate screening recommendations from the U.S. Department of Health and Human Services (HHS).
- September is Newborn Screening Awareness Month; each year, an estimated 4 million babies are reached by Newborn Screening (NBS) programs.
- In contrast, NxGen's carrier screening is not dependent on geographical location, timing, or any characteristics of the infant, which allows for more equitable care.